164 related articles for article (PubMed ID: 16679293)
21. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
22. Impact of rs361072 in the phosphoinositide 3-kinase p110beta gene on whole-body glucose metabolism and subunit protein expression in skeletal muscle.
Ribel-Madsen R; Poulsen P; Holmkvist J; Mortensen B; Grarup N; Friedrichsen M; Jørgensen T; Lauritzen T; Wojtaszewski JF; Pedersen O; Hansen T; Vaag A
Diabetes; 2010 Apr; 59(4):1108-12. PubMed ID: 20107106
[TBL] [Abstract][Full Text] [Related]
23. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.
Kubota N; Terauchi Y; Kubota T; Kumagai H; Itoh S; Satoh H; Yano W; Ogata H; Tokuyama K; Takamoto I; Mineyama T; Ishikawa M; Moroi M; Sugi K; Yamauchi T; Ueki K; Tobe K; Noda T; Nagai R; Kadowaki T
J Biol Chem; 2006 Mar; 281(13):8748-55. PubMed ID: 16431926
[TBL] [Abstract][Full Text] [Related]
24. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
25. Akt and Rac1 signaling are jointly required for insulin-stimulated glucose uptake in skeletal muscle and downregulated in insulin resistance.
Sylow L; Kleinert M; Pehmøller C; Prats C; Chiu TT; Klip A; Richter EA; Jensen TE
Cell Signal; 2014 Feb; 26(2):323-31. PubMed ID: 24216610
[TBL] [Abstract][Full Text] [Related]
26. Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction.
Schenk S; McCurdy CE; Philp A; Chen MZ; Holliday MJ; Bandyopadhyay GK; Osborn O; Baar K; Olefsky JM
J Clin Invest; 2011 Nov; 121(11):4281-8. PubMed ID: 21985785
[TBL] [Abstract][Full Text] [Related]
27. Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase.
Ueki K; Yballe CM; Brachmann SM; Vicent D; Watt JM; Kahn CR; Cantley LC
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):419-24. PubMed ID: 11752399
[TBL] [Abstract][Full Text] [Related]
28. T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.
Deane JA; Kharas MG; Oak JS; Stiles LN; Luo J; Moore TI; Ji H; Rommel C; Cantley LC; Lane TE; Fruman DA
Blood; 2007 Apr; 109(7):2894-902. PubMed ID: 17164340
[TBL] [Abstract][Full Text] [Related]
29. Hypoglycemic effect of D-chiro-inositol in type 2 diabetes mellitus rats through the PI3K/Akt signaling pathway.
Gao YF; Zhang MN; Wang TX; Wu TC; Ai RD; Zhang ZS
Mol Cell Endocrinol; 2016 Sep; 433():26-34. PubMed ID: 27212205
[TBL] [Abstract][Full Text] [Related]
30. Eurocristatine, a plant alkaloid from Eurotium cristatum, alleviates insulin resistance in db/db diabetic mice via activation of PI3K/AKT signaling pathway.
Zhang H; Hui J; Yang J; Deng J; Fan D
Eur J Pharmacol; 2020 Nov; 887():173557. PubMed ID: 32946868
[TBL] [Abstract][Full Text] [Related]
31. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake.
Storz P; Döppler H; Wernig A; Pfizenmaier K; Müller G
Eur J Biochem; 1999 Nov; 266(1):17-25. PubMed ID: 10542046
[TBL] [Abstract][Full Text] [Related]
32. Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85alpha.
Hallmann D; Trümper K; Trusheim H; Ueki K; Kahn CR; Cantley LC; Fruman DA; Hörsch D
J Biol Chem; 2003 Feb; 278(7):5099-108. PubMed ID: 12435753
[TBL] [Abstract][Full Text] [Related]
33. Expression of the splice variants of the p85alpha regulatory subunit of phosphoinositide 3-kinase in muscle and adipose tissue of healthy subjects and type 2 diabetic patients.
Lefai E; Roques M; Vega N; Laville M; Vidal H
Biochem J; 2001 Nov; 360(Pt 1):117-26. PubMed ID: 11695998
[TBL] [Abstract][Full Text] [Related]
34. Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes.
Meng Q; Qi X; Fu Y; Chen Q; Cheng P; Yu X; Sun X; Wu J; Li W; Zhang Q; Li Y; Wang A; Bian H
J Ethnopharmacol; 2020 Feb; 248():112326. PubMed ID: 31639486
[TBL] [Abstract][Full Text] [Related]
35. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway.
Gandhi GR; Jothi G; Antony PJ; Balakrishna K; Paulraj MG; Ignacimuthu S; Stalin A; Al-Dhabi NA
Eur J Pharmacol; 2014 Dec; 745():201-16. PubMed ID: 25445038
[TBL] [Abstract][Full Text] [Related]
36. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
[TBL] [Abstract][Full Text] [Related]
37. Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice.
Aoki K; Matsui J; Kubota N; Nakajima H; Iwamoto K; Takamoto I; Tsuji Y; Ohno A; Mori S; Tokuyama K; Murakami K; Asano T; Aizawa S; Tobe K; Kadowaki T; Terauchi Y
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E842-53. PubMed ID: 19176357
[TBL] [Abstract][Full Text] [Related]
38. Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation.
Wu JB; Kuo YH; Lin CH; Ho HY; Shih CC
J Agric Food Chem; 2014 Nov; 62(44):10717-26. PubMed ID: 25317836
[TBL] [Abstract][Full Text] [Related]
39. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats.
Anai M; Funaki M; Ogihara T; Terasaki J; Inukai K; Katagiri H; Fukushima Y; Yazaki Y; Kikuchi M; Oka Y; Asano T
Diabetes; 1998 Jan; 47(1):13-23. PubMed ID: 9421369
[TBL] [Abstract][Full Text] [Related]
40. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
Wang H; Knaub LA; Jensen DR; Young Jung D; Hong EG; Ko HJ; Coates AM; Goldberg IJ; de la Houssaye BA; Janssen RC; McCurdy CE; Rahman SM; Soo Choi C; Shulman GI; Kim JK; Friedman JE; Eckel RH
Diabetes; 2009 Jan; 58(1):116-24. PubMed ID: 18952837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
